why choose us

First received: September 01, 2022

Clinical Trial: A Study of TAK-341 in Treatment of Multiple System Atrophy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Multiple System Atrophy

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple Sy

Brief Summary: The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS).The study will enroll approximately 138 patients.Participants will receive a total of 13 intravenous infusions every 4 weeks approximately, these may be either of TAK-341 or placebo, after each infusion some blood samplings will be taken and other assessments completed.This trial will be conducted in North America, Europe and Asia.

Read more